Treace Medical Concepts, Inc. Common Stock TMCI
$4.37
+0.69%
at last close
Financials (TTM)
- Revenue
- $205.31 million
- Net Income
- $-59,516,000
- Net Margin
- -28.99%
- Return on Equity
- -87.86%
- Debt-to-Equity
- 0.83
- P/E Ratio
- —
- Price / Book
- 4.17
- Price / Sales
- 1.37
Over the trailing twelve months, Treace Medical Concepts, Inc. Common Stock generated revenue of $205.31 million and net income of $-59,516,000, a net margin of -28.99%.
At the last closing price of $4.37, TMCI trades at 1.37 times sales, with a market capitalization of $282.25 million.
Key Stats
- Last Close
- $4.37
- Market Cap
- $282.25 million
- 52-Week Range
- $1.17 – $7.78
- Average Volume
- 396K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.